BlueLinx (BXC) Q3 2024 earnings summary

Executive summary

• Q3 2024 net sales were $747 million (down 7.7%-8% year-over-year), with gross profit of $126 million and net income of $16 million, reflecting price deflation in both specialty and structural products, partially offset by volume gains.

• Adjusted net income was $17 million ($1.95 per share); adjusted EBITDA was $37 million (4.9% margin), including a $3.5 million net benefit from import duty-related matters.

• Free cash flow reached $54 million, with operating cash flow of $62 million and available liquidity of $873 million, including $526 million in cash.

• Continued execution on market share gain strategies, digital transformation, and geographic expansion, including greenfield and M&A opportunities.

• $15 million in share repurchases were completed in Q3, with $61 million remaining authorized.

Financial highlights

• Specialty products accounted for 70% of net sales ($519 million, down 7%-7.1%), with gross margin at 19.4% (18.7% excluding duty benefit); structural products accounted for $228 million (down 9%-9.1%), with gross margin at 11.0%.

• Total gross profit was $126 million (16.8% margin), down 40 basis points year-over-year.

• Adjusted EBITDA margin was 4.9% (4.4% excluding duty-related matters).

• Net income declined to $16 million from $24 million year-over-year; diluted EPS was $1.87, down from $2.71.

• Operating cash flow was $62 million, with capital expenditures of $8 million focused on facility and digital improvements.

Outlook and guidance

• Q4 specialty product gross margin expected in the 18%-19% range; structural gross margin in the 9%-10% range.

• Management expects improved pricing dynamics in 2025, likely in the back half of the year, as the housing market recovers.

• Anticipate capital investments for 2024 to be slightly below $40 million, focused on digital and facility upgrades.

• Tax rate for Q4 2024 expected between 24%-28%; annual effective tax rate for 2024 projected at 26%.

• Average daily sales volumes have improved slightly compared to Q3 2024.